Harufumi Maki
Appearances
- DateMay 20, 2024INTRODUCTION: Carcinoembryonic antigen (CEA) levels may change after preoperative chemotherapy discontinuation before surgery for colorectal liver metastases (CLM)…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 19, 2024Prognosis after hepatectomy for multifocal intrahepatic cholangiocarcinoma (iCCA) is worse than for unifocal iCCA with reported post-operative survival of under 2 years. As a result, multifocality must be carefully considered prior to resection…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center - DateMay 21, 2024INTRODUCTION: Pathologic response after preoperative chemotherapy has been associated with overall survival, and RAS mutational status could stratify patients with minor pathologic response (>50%)…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 21, 2024Background: Surgeons may consider parenchymal-sparing (PSH) or one-stage major hepatectomy (MH) for patients with bilateral colorectal liver metastases (CLM). However, outcomes of these two approaches for patients with advanced bilateral disease are underreported…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
